A Breakthrough in Pain Management: Inside the Promise of Journavx
Risk & Insurance - Apr 03, 2025
Enlyte’s Nikki Wilson offers a fresh take on a promising alternative to opioids, a first-of-its-kind FDA-approved non-addictive medication for pain. The post A Breakthrough in Pain Management: Inside the Promise of Journavx appeared first on Risk & Insurance. ...
Recommended Articles
Posted: Jul 08, 2025
Record capital levels create competitive reinsurance market, despite $60 billion in Q1 losses, Aon r...
Posted: Jul 07, 2025
High-cost treatments and shifting demographics reshape risk profiles for employers and insurers, QBE...
Posted: Jul 06, 2025
As AI adoption accelerates in workers’ comp, claims executives face a pivotal challenge: how to harn...